Erythropoietin ameliorates the motor and cognitive function impairments in a rat model of hepatic cirrhosis

Metabolic Brain Disease

Volumn 30, Issue 1, 2015, Pages 197-204

  Aghaei, Iraj ^a   Nazeri, Masoud ^b   Shabani, Mohammad ^a   Mossavinasab, Marziehsadat ^c   Mirhosseini, Fatemeh Khaleghi ^c   Nayebpour, Mohsen ^d   Dalili, Afshin ^e  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c PAYAME NOOR UNIVERSITY   (Iran)

^d Pouyesh Darou product Company   (Iran)

^e GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bile duct ligation; Erythropoietin; Hepatic encephalopathy; Neuroprotection

Indexed keywords

ALBUMIN; BILIRUBIN; ERYTHROPOIETIN; HEMOGLOBIN; NEUROPROTECTIVE AGENT;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BILE DUCT LIGATION; BILIRUBIN BLOOD LEVEL; BODY EQUILIBRIUM; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HEPATIC ENCEPHALOPATHY; LIVER CIRRHOSIS; LONG TERM CARE; MALE; MEMORY; MEMORY DISORDER; MORRIS WATER MAZE TEST; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MUSCLE STRENGTH; NEUROPROTECTION; NONHUMAN; OPEN FIELD TEST; PASSIVE AVOIDANCE TEST; POSTOPERATIVE CARE; RAT; ROTAROD TEST; SPATIAL LEARNING; TREATMENT DURATION; ANIMAL; AVOIDANCE BEHAVIOR; BILE DUCT; COMPLICATION; DRUG EFFECTS; DRUG SCREENING; HAND STRENGTH; LEARNING DISORDERS; LIGATION; LIVER CIRRHOSIS, EXPERIMENTAL; MAZE TEST; MEMORY DISORDERS; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PSYCHOLOGY; SPATIAL BEHAVIOR; SURGERY; WISTAR RAT;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

ANIMALS; AVOIDANCE LEARNING; BILE DUCTS; DRUG EVALUATION, PRECLINICAL; ERYTHROPOIETIN; EXPLORATORY BEHAVIOR; HAND STRENGTH; HEPATIC ENCEPHALOPATHY; LEARNING DISORDERS; LIGATION; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MAZE LEARNING; MEMORY DISORDERS; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; ROTAROD PERFORMANCE TEST; SPATIAL BEHAVIOR;

EID: 84921029559     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-014-9600-x     Document Type: Article

References (29)

1. Adamcio B, Sargin D, Stradomska A, Medrihan L, Gertler C, Theis F et al (2008) Erythropoietin enhances hippocampal long-term potentiation and memory. BMC Biol 6:37
2. Aghaei I, Shabani M, Doustar N, Nazeri M, Dehpour A (2014) Peroxisome proliferator-activated receptor-γ activation attenuates motor and cognition impairments induced by bile duct ligation in a rat model of hepatic cirrhosis. Pharmacol Biochem Behav 120:133–9
3. Bartesaghi S, Marinovich M, Corsini E, Galli CL, Viviani B (2005) Erythropoietin: a novel neuroprotective cytokine. Neurotoxicology 26:923–8
4. Brines M, Cerami A (2005) Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci 6:484–94
5. Butterworth RF (2002) Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab Brain Dis 17:221–7
6. Butterworth RF (2011) Hepatic encephalopathy: a central neuroinflammatory disorder? Hepatology 53:1372–6
7. Butterworth RF, Norenberg MD, Felipo V, Ferenci P, Albrecht J, Blei AT (2009) Experimental models of hepatic encephalopathy: ISHEN guidelines. Liver Int 29:783–8
8. Digicaylioglu M, Lipton SA (2001) Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades. Nature 412:641–7
9. Felipo V (2013) Hepatic encephalopathy: effects of liver failure on brain function. Nature Reviews Neuroscience
10. García-Ayllón M-S, Cauli O, Silveyra M-X, Rodrigo R, Candela A, Compañ A et al (2008) Brain cholinergic impairment in liver failure. Brain 131:2946–56
11. Hagemeyer N, Boretius S, Ott C, von Streitberg A, Welpinghus H, Sperling S et al (2012) Erythropoietin attenuates neurological and histological consequences of toxic demyelination in mice. Mol Med 18:628
12. Haghani M, Shabani M, Moazzami K (2013) Maternal mobile phone exposure adversely affects the electrophysiological properties of Purkinje neurons in rat offspring. Neuroscience 250:588–98
13. Hamidi G, Arabpour Z, Shabrang M, Rashidi B, Alaei H, Sharifi MR et al (2013) Erythropoietin improves spatial learning and memory in streptozotocin model of dementia. Pathophysiology 20:153–8
14. Huang L-T, Tiao M-M, Tain Y-L, Chen C-C, Hsieh C-S (2009) Melatonin ameliorates bile duct ligation-induced systemic oxidative stress and spatial memory deficits in developing rats. Pediatr Res 65:176–80
15. Javadi-Paydar M, Ghiassy B, Ebadian S, Rahimi N, Norouzi A, Dehpour AR (2013) Nitric oxide mediates the beneficial effect of chronic naltrexone on cholestasis-induced memory impairment in male rats. Behav Pharmacol 24:195–206
16. Leke R, Oliveira DL, Forgiarini LF, Escobar TD, Hammes TO, Meyer FS, et al. (2012) Impairment of short term memory in rats with hepatic encephalopathy due to bile duct ligation. Metabolic brain disease:1–6
17. Magen I, Avraham Y, Ackerman Z, Vorobiev L, Mechoulam R, Berry EM (2009) Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation. J Hepatol 51:528–34
18. Marti HH, Bernaudin M, Petit E, Bauer C (2000) Neuroprotection and angiogenesis: dual role of erythropoietin in brain ischemia. Physiology 15:225–9
19. Miskowiak K, O'Sullivan U, Harmer CJ (2007) Erythropoietin enhances hippocampal response during memory retrieval in humans. The Journal of Neuroscience 27:2788–92
20. Nasehi M, Ahmadzadeh O, Rezayof A, Zarrindast M-R (2013a) Does CA1 dopaminergic system play a role in cholestasis induced hypothermia? Pathophysiology 20:181–9
21. Nasehi M, Tackallou SH, Hasani I, Nasehi M (2013b) Cholestasis impaired spatial and non-spatial novelty detection in mice. Journal of Paramedical Sciences (JPS) Winter 4:2008–4978
22. Nasehi M, Yavari SA, Zarrindast MR (2013c) Synergistic effects between CA1 mu opioid and dopamine D1-like receptors in impaired passive avoidance performance induced by hepatic encephalopathy in mice. Psychopharmacology:1–14
23. Park KH, Choi N-Y, Koh S-H, Park H-H, Kim YS, Kim M-J et al (2011) L-DOPA neurotoxicity is prevented by neuroprotective effects of erythropoietin. Neurotoxicology 32:879–87
24. Ponce LL, Navarro JC, Ahmed O, Robertson CS (2012) Erythropoietin neuroprotection with traumatic brain injury. Pathophysiology
25. Probert PM, Ebrahimkhani MR, Oakley F, Mann J, Burt AD, Mann DA, et al. (2014) A reversible model for periportal fibrosis and a refined alternative to bile duct ligation. Toxicology Research
26. Razavinasab M, Shamsizadeh A, Shabani M, Nazeri M, Allahtavakoli M, Asadi-Shekaari M, et al. (2012) Pharmacological blockade of TRPV1 receptors modulates the effects of 6-OHDA on motor and cognitive functions in a rat model of Parkinson’s disease. Fundamental & clinical pharmacology
27. Shabani M, Hosseinmardi N, Haghani M, Shaibani V, Janahmadi M (2011) Maternal exposure to the CB1 cannabinoid agonist WIN 55212–2 produces robust changes in motor function and intrinsic electrophysiological properties of cerebellar Purkinje neurons in rat offspring. Neuroscience 172:139–52
28. Shabani M, Nazeri M, Parsania S, Razavinasab M, Zangiabadi N, Esmaeilpour K et al (2012) Walnut consumption protects rats against cisplatin-induced neurotoxicity. Neurotoxicology 33:1314–21
29. Singh HJ, Syeda TU, Rahul KM, Prasad VV, Diwan PV (2013) Erythropoietin protects Polychlorinated biphenyl (Aroclor 1254) induced neurotoxicity in mice. European journal of pharmacology